CN112516110B - Method for coating nano enzyme on cell membrane - Google Patents
Method for coating nano enzyme on cell membrane Download PDFInfo
- Publication number
- CN112516110B CN112516110B CN202011093134.4A CN202011093134A CN112516110B CN 112516110 B CN112516110 B CN 112516110B CN 202011093134 A CN202011093134 A CN 202011093134A CN 112516110 B CN112516110 B CN 112516110B
- Authority
- CN
- China
- Prior art keywords
- cell membrane
- membrane
- cell
- nano enzyme
- double
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
The invention discloses a method for coating a nano enzyme on a cell membrane. The cell membranes of different cells are cracked and purified, and the cells are coated on the surface of the double-layer hollow manganese silicate with catalase activity, so that the targeting property of the nano enzyme in vivo is enhanced, the circulation time in vivo is prolonged, the nano enzyme is effectively enriched at a tumor part, hydrogen peroxide is catalyzed to generate oxygen, and tumor hypoxia is relieved. The nano enzyme coated by the cell membrane has good biocompatibility, provides an idea for precise treatment and has a great clinical application prospect.
Description
The technical field is as follows:
the invention belongs to the technical field of nano materials, and relates to a method for coating a nano enzyme on a cell membrane.
Background art:
hypoxia is a common feature of most solid tumors, mainly due to the rapid proliferation of cancer cells that consume oxygen in large quantities and the inefficient uptake of oxygen by the microvasculature in the tumor. Hypoxia not only decreases the efficacy of anticancer therapies such as chemotherapy, photodynamic therapy and radiotherapy, but also increases tumor infiltration and metastasis, leading to death of cancer patients. In addition, hypoxic conditions promote the polarization of macrophages from M1, which has pathogen clearance and anti-tumorigenic properties, to M2, which has pro-angiogenic and pro-tumorigenic properties, leading to a reduced attack of the immune system on tumor cells. Therefore, it is important to alleviate tumor hypoxia.
Traditional medical approaches have attempted to increase tumor oxygen levels by hyperbaric oxygen inhalation. However, the inefficient microvasculature at the tumor site prevents oxygenation of hyperbaric blood, and the potential toxicity of excessive inhaled oxygen also prevents clinical application of hyperbaric oxygen inhalation. It has been reported that some nanoenzymes can promote tumor oxygenation by catalyzing hydrogen peroxide at the tumor site to generate oxygen, such as manganese dioxide. Compared with natural enzymes, the nano-enzyme has higher stability, adjustable enzyme activity and lower production cost, and shows good application prospect in the aspect of biomedical use.
However, the synthetic nanoenzymes, which act as foreign substances and are rapidly eliminated upon injection into the body, shorten the circulation time and limit the therapeutic effect, cause various degrees of immune response although they can be improved by surface modification with polymers. In addition, the nanoenzyme can be passively targeted to the tumor site through the EPR effect, but the delivery efficiency is only 0.7%. Therefore, it is important to realize immune escape of the nano material, prolong the half-life of the nano material and enhance the tumor targeting property of the nano material. Functional protein exists on the surface of the cell membrane, and the blood circulation half-life period of the nano particles can be prolonged by utilizing the cell membrane coating, the nano particles are prevented from being identified by an immune system, and the active targeting property of nano enzyme is enhanced.
The invention content is as follows:
in order to solve the problems of poor targeting property and short half-life of the nano enzyme in vivo, the invention aims to provide a method for coating the nano enzyme double-layer hollow nano manganese silicate by a cell membrane. In order to realize the purpose, the invention firstly utilizes hypotonic solution or freeze-thaw cycle to crack cells and extract cell membranes, and then wraps the nano enzyme into the biological membrane in an extrusion mode, and finally can form uniform membrane-coated nano enzyme.
The technical scheme of the invention is as follows:
a method for coating nano enzyme by cell membrane comprises the following steps:
extracting macrophage cell membranes: resuspend RAW 264.7 macrophages in Tris-magnesium buffer (pH 7.4, Tris and MgCl)2The mass ratio of (1): 12.72) concentration of 2.5X 107one/mL and extruded through an Avestin liposome extruder without polycarbonate membrane to destroy cells. The cell homogenate was mixed with 1M sucrose to a final concentration of 0.25M sucrose and then centrifuged at 2000g and 4 ℃ for 10 minutes. The supernatant was collected and centrifuged further at 3000g and 4 ℃ for 30min to collect cell membranes. The cell membranes were washed with Tris-magnesium buffer at 4 ℃ and collected by centrifugation at 3000g at 4 ℃ for 30 min. Resuspended in phosphate buffer solution at a ratio of RAW 264.7 macrophages to phosphate buffer solution of 2.5X 107The method comprises the following steps: 1 mL. Mixing the obtained cell membrane with double-layer hollow manganese silicate, wherein the mass ratio of the cell membrane suspension volume to the double-layer hollow manganese silicate is 1mL:200 μ g, passing through a polycarbonate membrane with the aperture of 200nm for at least 25 times, centrifuging to collect the nano enzyme coated by the cell membrane, wherein the centrifugal force is 8950g, the centrifugation time is 10min, and the operation is carried out at room temperature.
The cell membrane coated nanoenzyme synthesized by the invention has the advantages of uniform appearance and size, good dispersibility, simple synthesis method and process, high repeatability, economy, good biocompatibility, higher targeting property, longer in-vivo circulation time and peroxidase-like activity, and has wide application prospect in the field of biomedicine.
Description of the drawings:
fig. 1 is a TEM image of the resulting double-layered hollow manganese silicate nanoparticle.
Fig. 2 is a TEM image of the prepared macrophage membrane-coated double-layered hollow manganese silicate nanoparticle.
FIG. 3 shows peroxidase-like activity at different concentrations of the double-layered hollow manganese silicate nanoparticles coated with the macrophage membrane prepared in the above method.
Detailed Description
Example 1
The transmission electron micrograph of the double-layer hollow manganese silicate nanoparticle is shown in FIG. 1, and the particle size is 150 nm.
Example 2
Resuspend RAW 264.7 macrophages in Tris-magnesium buffer (TM-buffer, pH 7.4, 0.01M Tris and 0.001M MgCl2) At a concentration of 2.5X 107one/mL and extruded through an Avestin liposome extruder without polycarbonate membrane to destroy cells. Mixing the cell homogenate with sucrose solution with concentration of 342.3g/L at a volume ratio of 1:3, centrifuging for 10min at centrifugal force of 2000g and centrifugal temperature of 4 deg.C, collecting supernatant, centrifuging again at rotation speed of 3000g and temperature of 4 deg.C. Collecting the precipitate, washing with Tris-magnesium buffer solution at 4 deg.C, centrifuging at 3000g centrifugal force at 4 deg.C for 30min, and suspending in phosphate buffer solution at a ratio of RAW 264.7 macrophage to phosphate buffer solution of 2.5 × 107The method comprises the following steps: 1 mL. Mixing the obtained cell membrane with a double-layer hollow manganese silicate solution, wherein the mass ratio of the cell membrane suspension volume to the double-layer hollow manganese silicate is 1mL:200 mug, passing through a polycarbonate membrane with the aperture of 200nm, the centrifugal force is 8950g, the centrifugal time is 10min, and collecting double-layer hollow manganese silicate nanoparticles coated by a cell membrane at room temperature. The sample produced is shown in FIG. 2.
Example 3
0-400 mug mL of the double-layer hollow manganese silicate coated by the cell membrane is dispersed in 1mL of phosphate buffer solution, and the weight ratio of the double-layer hollow manganese silicate to the phosphate buffer solution is 1: 15, 3',5,5' -tetramethylbenzidine and hydrogen peroxide, and the ultraviolet absorption was measured after standing at room temperature for 10 min.
Claims (4)
1. A method for coating nano enzyme on cell membrane is characterized in that: mixing the cell membrane with double-layer hollow manganese silicate with peroxidase-like property in phosphate buffer solution, extruding through membrane, centrifuging and collecting double-layer hollow manganese silicate coated by cell membrane;
dispersing RAW 264.7 macrophage in Tris-magnesium buffer solution, adjusting RAW 264.7 macrophage number to 2.5 × 107Placing the cells/mL at 4 ℃, and after 12 hours, extruding the cells by an extruder for more than 20 times to destroy the cells to obtain cell homogenate; mixing the cell homogenate with a sucrose solution with a concentration of 342.3g/L at a volume ratio of 1:3, centrifuging for 10min at a centrifugal force of 2000g and a centrifugal temperature of 4 ℃, collecting the supernatant, and centrifuging again at a rotating speed of 3000g and a temperature of 4 ℃; collecting the precipitate, washing with Tris-magnesium buffer at 4 deg.C, centrifuging at 3000g centrifugal force at 4 deg.C for 30min, and suspending in phosphate buffer solution at ratio of RAW 264.7 macrophage to phosphate buffer solution of 2.5 × 107The method comprises the following steps: 1 mL.
2. The method of claim 1, wherein the mass ratio of the cell membrane suspension volume to the double layer hollow manganese silicate is 1mL:200 μ g.
3. The method of claim 1, wherein the polycarbonate membrane has a pore size of 200nm and is repeatedly pressed through the filter membrane more than 25 times.
4. The method of claim 1, wherein the centrifugation is performed at room temperature at a centrifugal force of 8950g for 10min to collect the cell membranes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011093134.4A CN112516110B (en) | 2020-10-13 | 2020-10-13 | Method for coating nano enzyme on cell membrane |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011093134.4A CN112516110B (en) | 2020-10-13 | 2020-10-13 | Method for coating nano enzyme on cell membrane |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112516110A CN112516110A (en) | 2021-03-19 |
CN112516110B true CN112516110B (en) | 2022-05-13 |
Family
ID=74979138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011093134.4A Active CN112516110B (en) | 2020-10-13 | 2020-10-13 | Method for coating nano enzyme on cell membrane |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112516110B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113750232B (en) * | 2021-09-12 | 2023-06-02 | 重庆医科大学 | Macrophage membrane coated arginine deiminase/catalase/IR 780 nanoparticle, preparation method and application |
CN114306581B (en) * | 2021-12-31 | 2023-06-02 | 重庆医科大学 | Fusion cell membrane coated uricase/catalase lipid nanoparticle and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019050998A1 (en) * | 2017-09-05 | 2019-03-14 | GLAdiator Biosciences, Inc. | Method of targeting exosomes |
CN110711249A (en) * | 2019-09-19 | 2020-01-21 | 北京化工大学 | Preparation method of lysosome membrane-coated nanoparticles |
CN110876805A (en) * | 2019-12-06 | 2020-03-13 | 郑州大学 | Preparation method and application of macrophage membrane bionic bismuth triselenide nanoparticles |
CN110974978A (en) * | 2019-12-23 | 2020-04-10 | 暨南大学 | Nano-catalyst for treating tumor and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130336897A1 (en) * | 2012-06-18 | 2013-12-19 | Gerald L. Wolf | Theranosis of macrophage-associated diseases with ultrasmall superparamagnetic iron oxide nanoparticles (uspio) |
-
2020
- 2020-10-13 CN CN202011093134.4A patent/CN112516110B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019050998A1 (en) * | 2017-09-05 | 2019-03-14 | GLAdiator Biosciences, Inc. | Method of targeting exosomes |
CN110711249A (en) * | 2019-09-19 | 2020-01-21 | 北京化工大学 | Preparation method of lysosome membrane-coated nanoparticles |
CN110876805A (en) * | 2019-12-06 | 2020-03-13 | 郑州大学 | Preparation method and application of macrophage membrane bionic bismuth triselenide nanoparticles |
CN110974978A (en) * | 2019-12-23 | 2020-04-10 | 暨南大学 | Nano-catalyst for treating tumor and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
Bioengineered Macrophages Can Responsively Transform into Nanovesicles To Target Lung Metastasis;Haiqiang Cao等;《Nano Letters》;20180720;第18卷;第4762-4770页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112516110A (en) | 2021-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy | |
CN112516110B (en) | Method for coating nano enzyme on cell membrane | |
CN110755613A (en) | Preparation and application of light-triggered erythrocyte membrane-coated NO nano bionic donor material | |
Li et al. | A smart nanoplatform for synergistic starvation, hypoxia-active prodrug treatment and photothermal therapy mediated by near-infrared-II light | |
CN113521098B (en) | Platinum (IV) and cRGD modified GA/Fe nano-particle carried doxorubicin and method for targeted therapy of tumors by using same | |
Ruan et al. | Nanomaterials for tumor hypoxia relief to improve the efficacy of ROS-generated cancer therapy | |
CN113289030A (en) | Preparation method of targeted long-circulating nano-drug carrier for photothermal synergistic chemotherapy | |
CN110898229A (en) | Preparation method of double-response nano prodrug for cancer synergistic treatment | |
Gu et al. | Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapy | |
CN111000825A (en) | Bionic nano-carrier with dual functions of oxidation and antioxidation, and preparation method and application thereof | |
Du et al. | Oxygen-deficient titanium dioxide-loaded black phosphorus nanosheets for synergistic photothermal and sonodynamic cancer therapy | |
Li et al. | A multifunctional nanoamplifier with self-enhanced acidity and hypoxia relief for combined photothermal/photodynamic/starvation therapy | |
Shi et al. | Endo/exo-genous dual-stimuli responsive gold nanotetrapod-based nanoprobe for magnetic resonance imaging and enhanced multimodal therapeutics by amplifying· OH generation | |
CN110711249B (en) | Preparation method of lysosome membrane-coated nanoparticles | |
Wang et al. | Light‐Driven Biomimetic Nanomotors for Enhanced Photothermal Therapy | |
CN115708813B (en) | Multifunctional manganese-based nanoparticle and preparation method and medical application thereof | |
CN115944649A (en) | Immune-enhanced targeted hollow manganese dioxide radiosensitizer as well as preparation method and application thereof | |
CN112791061A (en) | Preparation method of multi-stage bionic nano-drug carrier with targeting long circulation | |
CN109550050B (en) | Melanin-loaded molybdenum dioxide drug-loaded compound and preparation and application thereof | |
Tang et al. | Cancer cell membrane biomimetic mesoporous nanozyme system with efficient ROS generation for antitumor chemoresistance | |
Liu et al. | Photothermal-accelerated urease-powered human serum albumin nanomotor for rapid and efficient photothermal and photodynamic cancer combination therapy | |
CN111759808A (en) | Liposome-graphene-gold composite nano material and preparation method and application thereof | |
Meng et al. | An NIR-II light-responsive nanoplatform for photothermal and enhanced photodynamic synergistic therapy toward drug-resistant bacterial infection and hypoxia relief in subcutaneous wound healing | |
CN114159466B (en) | Hydroxyapatite/saccharomycete biological hybrid material and preparation method and application thereof | |
CN115463221A (en) | Nano-targeting drug-loaded compound and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |